The Pfizer-BioNTech COVID-19 vaccine became the first vaccine to receive the World Health Organisation (WHO) validation for emergency use since the pandemic outbreak.
“Regulatory experts from around the world reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy and quality. They found that the vaccine met the must-have criteria for safety, efficacy and that the benefits of using it to address the disease offset potential risks,” WHO Tweeted.
The Pfizer/BioNTech #COVID19 vaccine today became the first vaccine to receive WHO validation for emergency use since the outbreak began.
— World Health Organization (WHO) (@WHO) December 31, 2020
Equitable global access to vaccines is crucial to combat the pandemic.
👉 https://t.co/7WNcHhc3z8 pic.twitter.com/Kyjv5RNzjB
Regulatory experts from around the 🌐 reviewed the data on the Pfizer/BioNTech #COVID19 vaccine’s safety, efficacy & quality. They found that the vaccine met the must-have criteria for safety & efficacy & that the benefits of using it to address the disease offset potential risks pic.twitter.com/XSCQIDlw9b
— World Health Organization (WHO) (@WHO) December 31, 2020
Kenya offers temporary amnesty to undocumented East Africans amid crackdown fears
7 Indonesian airports remain shut due to volcanic ash from Anak Krakatau
Bolivia confirms 7 deaths after military base explosion
Israeli strikes on southern Lebanese town kill 11, state news agency says
Nepal marks national mourning day after deadly flood
Far-right AfD wins historic victory in German state election
At least 5 killed in Amazon Prime Air cargo plane crash in Miami
Israeli strike kills 2 in Gaza, medics say
